Archive | Quarterly Report

RSS feed for this section

SIAPS Activity and Product Status Report: Year 5, Quarter 2

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the January through March 2016 period.

Read full story · Comments are closed

Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update

According to the World Health Organization (WHO), the number of malaria deaths malaria mortality rates fell by 48% globally, and the number of malaria cases by 18% between 2000 and 2015. During this period, it is estimated that 6.2 million fewer malaria deaths occurred globally, primarily as a result of the scale-up of interventions. However, much remains to be done. Despite impressive gains in malaria intervention coverage, millions of people still do not receive the services they need.

Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.

The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.

This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between October and December 2015.

Read full story · Comments are closed

Strengthening the Malaria Supply Chain in Niger

SIAPS Program provides support to the US President’s Malaria Initiative (PMI) country programs to address challenges to ensuring an uninterrupted supply of high-quality medicines and commodities as well as their appropriate use. SIAPS Program collaborates with PMI and field programs to strengthen pharmaceutical management systems for the benefit of national malaria control programs (NMCP). In Niger, SIAPS is supporting the NMCP to strengthen the systems for malaria commodities management.  This report summarizes activities carried out in Niger from October 1, 2015, to December 30, 2015.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 5, Quarter 1

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the October through December 2015 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 4, Quarter 4

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the July through September 2015 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 4, Quarter 3

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the April through June 2015 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 4, Quarter 2

The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, awarded by USAID in September 2011, strengthens the management of essential medicines and health supplies so that more people can access the health care they need. Now in its fourth year, SIAPS works with local counterparts and partners in 23 countries, and 2 regional programs in, Latin America and West Africa. SIAPS takes a comprehensive approach to improving pharmaceutical systems: enhancing countries’ capacity to procure and distribute high-quality medicines and health technologies, while working with local partners to develop strong systems for pharmaceutical financing, human resources, governance, information, service delivery, and pharmacovigilance. By promoting local ownership of wide-ranging initiatives, stronger, more sustainable health systems overall are fostered. The program’s five result areas are as follows—

  • Intermediate Result 1: Pharmaceutical sector governance strengthened
  • Intermediate Result 2: Capacity for pharmaceutical supply management and services increased and enhanced
  • Intermediate Result 3: Information for decision-making challenge in the pharmaceutical sector addressed
  • Intermediate Result 4: Financing strategies and mechanisms strengthened to improve access to medicines
  • Intermediate Result 5: Pharmaceutical services improved to achieve desired health outcomes

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the January through March 2015 period.

Read full story · Comments are closed

Malaria PMI Quarterly Updates October-December 2014

According to the 2013 World Malaria Report,1 malaria incidence was reduced by about 31% and mortality rates by 49%in the World Health Organization (WHO) African Region between 2000 and 2012. These substantial reductions occurred as a result of a major scale-up of vector control interventions, diagnostic testing, and treatment with artemisinin-based combination therapies (ACTs). However, much remains to be done. The disease still took an estimated 627,000 lives in 2012,2 mostly children under five years of age in Africa.

Working closely with the President’s Malaria Initiative (PMI) both in Washington and in PMI focus countries, the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on PMI’s malaria program priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.

This report briefly describes the major activities that SIAPS conducted at the global level and in each of the above mentioned countries and regions between September and December 2014.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 4, Quarter 1

The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, awarded by USAID in September 2011, strengthens the management of essential medicines and health supplies so that more people can access the health care they need. Now in its third year, SIAPS works with local counterparts and partners in 23 countries, and 2 regional programs in East Africa, Latin America and West Africa. SIAPS takes a comprehensive approach to improving pharmaceutical systems: enhancing countries’ capacity to procure and distribute high-quality medicines and health technologies, while working with local partners to develop strong systems for health financing, human resources, governance, information, service delivery, and pharmacovigilance. By promoting local ownership of wide-ranging initiatives, stronger, more sustainable health systems overall are fostered.

The program’s five result areas are as follows:

  • Intermediate Result 1: Pharmaceutical sector governance strengthened
  • Intermediate Result 2: Capacity for pharmaceutical supply management and services increased and enhanced
  • Intermediate Result 3: Information for decision-making challenge in the pharmaceutical sector addressed
  • Intermediate Result 4: Financing strategies and mechanisms strengthened to improve access to medicines
  • Intermediate Result 5: Pharmaceutical services improved to achieve desired health outcomes

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the October through December 2014 period.

Read full story · Comments are closed

Malaria Quarterly Updates January–March 2014

This report briefly describes the major activities that SIAPS conducted at the global level and in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, and South Sudan between January and March 2014.

Read full story · Comments are closed